2- chloro- N- (2- (2- (5- methylpyridin- 2- ylamino)- 2- oxoethylthio)benzo(d)thiazol- 6- yl) acetamide

01/01/2013 - "In this study, we found that YLT322 showed growth inhibition against a broad spectrum of human cancer cells and induced apoptosis of HepG2 cells in a dose- and time-dependent manner. "
01/01/2013 - "Moreover, YLT322 suppressed the growth of established tumors in xenograft models in mice without obvious side effects. "
01/01/2013 - "These results suggest that YLT322 may be a potential candidate for cancer therapy."
01/01/2013 - "YLT322, a novel synthesized benzothiazole derivative, exhibits potent anti-tumor activity via inducing apoptosis both in vitro and in vivo. "
01/01/2013 - "A novel benzothiazole derivative YLT322 induces apoptosis via the mitochondrial apoptosis pathway in vitro with anti-tumor activity in solid malignancies."